Drug
AT 007
AT 007: highest development phase Phase 3, developed by Applied Therapeutics. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Applied Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| AT-007 NCT05418829 | Phase 3 | Classic Galactosemia |
| AT-007 NCT04902781 | Phase 2/3 | Classic Galactosemia |
| AT-007 NCT05397665 | Phase 2/3 | Hereditary Neuropathy Caused by SORD Deficiency |
| AT-007 NCT04117711 | Phase 1/2 | Classic Galactosemia |
Latest
No recent events.
Follow AT 007 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.